Status:
COMPLETED
Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children
Lead Sponsor:
Allergopharma GmbH & Co. KG
Conditions:
Allergic Rhinoconjunctivitis
Eligibility:
All Genders
4-11 years
Phase:
PHASE3
Brief Summary
Evaluation of safety and efficacy of sublingual immunotherapy with grass pollen allergens formulated as solution in comparison to a symptomatic standard treatment with add on placebo in grass pollen a...
Detailed Description
Although highly effective, subcutaneous administration of allergens may cause inconvenience in some patients. Alternative routes, e.g. nasal and oral, have therefore been investigated to find an immun...
Eligibility Criteria
Inclusion
- 4 - \<12 years (at the time of inclusion)
- Positive SPT
- Positive EAST
- Positive CPT
Exclusion
- Serious chronic diseases
- Other perennial allergies
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT00841256
Start Date
February 1 2008
End Date
August 1 2015
Last Update
October 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Paediatrie Universitätsmedizin Berlin
Berlin, State of Berlin, Germany, 13353